SCHEMBL16124418

SCHEMBL16124418

O=C(CCc1cc(I)c(Oc2ccc(O)c(C(=O)NCc3ccccc3)c2)c(I)c1)NCCO

nearest known ligand 0.63

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ PCNA P12004 9/20 0.63
▸ THRB P10828 11/20 0.55
▸ THRA P10827 10/20 0.55
▸ POLB P06746 2/20 0.51
▸ HIF1A Q16665 2/20 0.51
▸ MAPK1 P28482 1/20 0.51
▸ ERCC1 P07992 1/20 0.46
▸ ERCC4 Q92889 1/20 0.46
▸ ABCB11 O95342 1/20 0.43
▸ LMNA P02545 1/20 0.43
▸ CYP1A2 P05177 1/20 0.43
▸ PGR P06401 1/20 0.43
▸ CHRM2 P08172 1/20 0.43
▸ HTR1A P08908 1/20 0.43
▸ ADRA2A P08913 1/20 0.43
▸ ADORA3 P0DMS8 1/20 0.43
▸ AR P10275 1/20 0.43
▸ CYP2C9 P11712 1/20 0.43
▸ GABRA1 P14867 1/20 0.43
▸ HPGD P15428 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16124463 0.93 PCNA (0.53) PCNATHRBTHRAPOLBHIF1A
SCHEMBL16124501 0.89 THRB (0.65) PCNATHRBTHRAPOLBHIF1A
SCHEMBL16124417 0.89 PCNA (0.63) PCNATHRBTHRAPOLBHIF1A
SCHEMBL16124422 0.86 PCNA (0.56) PCNATHRBTHRAPOLBHIF1A
SCHEMBL16124464 0.81 PCNA (0.53) PCNATHRBTHRAPOLBHIF1A
SCHEMBL14553380 0.79 THRB (0.52) PCNATHRBTHRALMNA
SCHEMBL14485275 0.78 PCNA (1.00) PCNATHRBTHRAPOLBHIF1A
SCHEMBL14485284 0.76 HPGD (0.51) PCNATHRBTHRAPOLBHIF1A
SCHEMBL16124502 0.76 THRB (0.66) PCNATHRBTHRAPOLBHIF1A
SCHEMBL14553372 0.76 THRB (0.53) PCNATHRBTHRAERCC1ERCC4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20140288077-A1 SUBSTITUTED 4-PHENOXYPHENOL ANALOGS AS MODULATORS OF PROLIFERATING CELL NUCLEAR ANTIGEN ACTIVITY ST. JUDE CHILDREN'S RESEARCH HOSPITAL (US) 2014-09-25 — — US disclosed
US-20140288077-A1 SUBSTITUTED 4-PHENOXYPHENOL ANALOGS AS MODULATORS OF PROLIFERATING CELL NUCLEAR ANTIGEN ACTIVITY ST. JUDE CHILDREN'S RESEARCH HOSPITAL (US) 2014-09-25 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20140288077-A1 SUBSTITUTED 4-PHENOXYPHENOL ANALOGS AS MODULATORS OF PROLIFERATING CELL NUCLEAR ANTIGEN ACTIVITY MKI67, PCNA, PCLAF PCNA 2/4885THRB 2853/4885THRA 3069/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback